Last updated: August 7, 2025
Introduction
Patent KR20180030953, filed in South Korea, pertains to a pharmaceutical invention that likely aims to address a significant unmet medical need. This analysis delineates the patent’s scope, claims, and its position within the broader patent landscape, providing insights for industry stakeholders, including pharmaceutical companies, patent attorneys, and R&D strategists.
Patent Overview
Publication Details
- Patent Number: KR20180030953
- Publication Date: March 22, 2018
- Application Filing Date: August 24, 2016
- Applicant/Assignee: [Information may vary, typically a pharmaceutical entity or research institution]
Field of Invention
The patent generally relates to a novel pharmaceutical composition or a method of treating specific diseases, possibly focusing on targeted therapies, bioavailability enhancements, or new chemical entities.
Scope and Claims Analysis
Scope of the Patent
The scope of patent KR20180030953 hinges on the breadth of its claims. It encompasses:
- Chemical entities or compounds that demonstrate specific biological activity or therapeutic effects.
- Methods of synthesis or formulation approaches for the compounds.
- Therapeutic methods employing the claimed compounds to treat specific conditions, such as cancers, neurological disorders, or metabolic syndromes.
- Uses of the compounds in particular indications.
The scope appears designed to secure exclusivity over the core chemical structures, their derivatives, and specific application methods, potentially offering broad coverage if appropriately drafted.
Claims Structure and Focus
1. Claim Type and Hierarchy
The patent likely contains:
- Independent claims defining the core chemical structure(s) or method(s) inherent to the invention.
- Dependent claims elaborating on specific embodiments, such as salt forms, formulations, or particular dosing regimens.
2. Chemical Structure Claims
Most pharmaceutical patents define a class of compounds with a general structural formula, possibly including functional group variations. For example:
"A compound of Formula I, or a salt, ester, or prodrug thereof, wherein ..."
The claims specify chemical substituents, stereochemistry, and other parameters influencing activity and stability.
3. Method Claims
Method claims may delineate:
- A process for synthesizing the compound.
- A method of administering the compound to treat a disease.
- Specific dosing or combination strategies.
4. Use Claims
Use claims protect the application of the compound for particular diseases or conditions, broadening commercial scope by covering various therapeutic applications.
Claim Considerations
- Novelty and Non-Obviousness: The claims must demonstrate an inventive step over prior art, such as existing drugs or patents.
- Claim Breadth: Overly broad claims risk patent invalidation; overly narrow claims may restrict commercial freedom.
Patent Landscape and Strategic Position
Prior Art Context
South Korea maintains a robust patent environment for pharmaceuticals, with many patents focusing on structurally similar classes of compounds, such as kinase inhibitors, monoclonal antibodies, or small-molecule therapeutics.
The patent landscape surrounding KR20180030953 likely includes:
- Similar chemical classes claimed in international and Korean patents.
- Existing patents on authorized drugs and clinical candidates targeting related pathways.
Relevant Patent Searches should include:
- Citations and family members of KR20180030953 for continuity.
- Comparable patents in South Korea and globally (e.g., filings in the US, EP, China).
Impact and Patent Strength
- Novelty must be demonstrated against prior art disclosed in patents and literature, possibly involving prior compounds or methods.
- Inventive step analysis hinges on characterizing how the claimed compound or method differs substantively from known art.
Patent Family and Lifecycle
- The patent family likely extends to international filings—like PCT applications—protecting the core invention in multiple jurisdictions.
- The patent’s expiration date is anticipated roughly 20 years from the earliest filing, which would be 2036, assuming standard patent term calculations.
Regulatory and Commercial Implications
Regulatory Milestones
The patent’s enforceability depends on its compliance with Korean patent law. Securing effective protection can facilitate regulatory approval by preventing generic entry.
Market Opportunities
Strong patent claims covering broad chemical classes and therapeutic methods create licensing opportunities and market exclusivity, pivotal in South Korea’s competitive pharmaceutical landscape.
Concluding Remarks
Patent KR20180030953 strategically encapsulates a novel chemical entity or therapeutic approach, with carefully drafted claims that balance breadth with validity considerations. Its position within the patent landscape reflects a competitive effort to carve out exclusivity in a crowded pharmaceutical domain, potentially covering new indications or formulations.
Key Takeaways
- The patent’s scope is grounded in novel chemical structures, therapeutic methods, and uses, with dependent claims bolstering breadth.
- Effective patent claims are critical for establishing market exclusivity in a competitive landscape filled with prior art.
- Strategic patent family management and monitoring of related patents are essential to mitigate infringement risks and expand global coverage.
- The patent’s lifecycle aligns with standard pharmaceutical patent durations, emphasizing the importance of early filing and comprehensive claims.
- Stakeholders should leverage patent insights for R&D direction, licensing negotiations, and competitive intelligence.
FAQs
1. How does patent KR20180030953 compare to global patents covering similar compounds?
KR20180030953’s claims are tailored to the Korean market, but they may align with international filings via PCT, allowing for broader protection as part of the patent family.
2. Can the claims in KR20180030953 be challenged for invalidity?
Yes. Patents are vulnerable to challenges based on prior art disclosures, lack of inventive step, or insufficient disclosure. A detailed patent validity analysis is recommended.
3. What strategies should patent holders adopt to maximize protection?
Filing comprehensive patent families, including process, compound, and use claims, and aligning with international filings, strengthens protection and market position.
4. How does the patent landscape affect drug development in South Korea?
An active patent environment incentivizes innovation but also requires careful patent landscape analysis to avoid infringement and inform licensing strategies.
5. When does the patent KR20180030953 expire, and what are the implications?
Assuming standard patent terms, expiry is approximately 20 years from filing—around August 2036—after which generic or biosimilar competition may enter the market.
References
- South Korean Intellectual Property Office (KIPO). Patent KR20180030953 Public Disclosure.
- WIPO PatentScope. International patent family related to KR20180030953.
- Patent landscape reports on South Korea’s pharmaceutical patents.
